NCOA3
protein-codingnuclear receptor coactivator 3, the group of Basic helix-loop-helix proteins|Lysine acetyltransferases|PAS domain containing
Gene summary
The protein encoded by this gene is a nuclear receptor coactivator that interacts with nuclear hormone receptors to enhance their transcriptional activator functions. The encoded protein has histone acetyltransferase activity and recruits p300/CBP-associated factor and CREB binding protein as part of a multisubunit coactivation complex. This protein is initially found in the cytoplasm but is translocated into the nucleus upon phosphorylation. Several transcript variants encoding different isoforms have been found for this gene. In addition, a polymorphic repeat region is found in the C-terminus of the encoded protein. [provided by RefSeq, Mar 2010]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~155.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0019587
Submitter: PanelApp Australia
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to NCOA3 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_181659.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 4 | 4 | 8 | |||
| missense | 1 | 166 | 10 | 1 | 178 | |
| nonsense | 4 | 4 | ||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 1 | 1 | ||||
| Total | 1 | 0 | 175 | 14 | 1 | 191 |
Highest pathogenic variant AF is 0.00023542444
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_858045.1 | 21 | MANE Select | |
| Ensembl | ENSP00000361066.3 | 21 | MANE Select | |
| RefSeq | NP_001167558.1 | 21 | Standard | |
| RefSeq | NP_001167559.1 | 21 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Breast cancer - Homo sapiens (human)
- Thyroid hormone signaling pathway - Homo sapiens (human)
- Estrogen signaling pathway - Homo sapiens (human)
- Pathways in cancer - Homo sapiens (human)
- Glucocorticoid Pathway (Peripheral Tissue), Pharmacodynamics
Biological Process
- positive regulation of gene expression
- histone acetylation
- androgen receptor signaling pathway
- cellular response to hormone stimulus
- receptor transactivation
Molecular Function
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II complex binding
- transcription coactivator activity
- histone acetyltransferase activity
- protein binding
Cellular Component
- nuclear chromatin
- nucleus
- nucleoplasm
- cytoplasm
- cytosol
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000371998
- Coding exons
- 21
- Length
- 155021
- Individuals with no LoFs
- 125462
- Homozygous LoFs
- 2
- Heterozygous LoFs
- 284
- Defined
- 125748
- p
- 0.00114
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.33 | 672 | 776 | 0.866 | 0.0000390 | 9463 |
| Missense (PolyPhen) | 187 | 251.23 | 0.74432 | 3006 | ||
| Synonymous | 0.111 | 265 | 267 | 0.991 | 0.0000133 | 2685 |
| Loss of Function | 6.15 | 16 | 72.5 | 0.221 | 0.00000411 | 754 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.0077 | 0.0066 | notable |
| Latino/Admixed American | 0.00041 | 0.00040 | rare |
| Ashkenazi Jewish | 0.000099 | 0.000099 | rare |
| East Asian | 0.00033 | 0.00033 | rare |
| Finnish | 0.00014 | 0.00014 | rare |
| European (Non-Finnish) | 0.00092 | 0.00087 | rare |
| South Asian | 0.0018 | 0.0017 | notable |
| Other | 0.00067 | 0.00065 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Nuclear receptor coactivator that directly binds nuclear receptors and stimulates the transcriptional activities in a hormone-dependent fashion. Plays a central role in creating a multisubunit coactivator complex, which probably acts via remodeling of chromatin. Involved in the coactivation of different nuclear receptors, such as for steroids (GR and ER), retinoids (RARs and RXRs), thyroid hormone (TRs), vitamin D3 (VDR) and prostanoids (PPARs). Displays histone acetyltransferase activity. Also involved in the coactivation of the NF-kappa-B pathway via its interaction with the NFKB1 subunit.;
Recessive Scores
- pRec
- 0.126
Intolerance Scores
- LoFtool
- 0.608
- RVIS EVS
- -1.23
- RVIS percentile EVS
- 5.54
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 1.00
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | High |
| Cancer | Medium | Medium | Medium |